このビデオポッドキャストスタジオは、ボストンのバイオテクノロジーの専門家が対面でのディスカッションを通じて洞察を共有し、ケンドールスクエアの中心での革新を紹介するためのスペースを提供します。
Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP to create broad T-cell responses
S1 E15 • 41 mins • Apr 22, 2025
Charts
- 172NEW
- 185Increased by 0
- 200Decreased by 7
- 41Increased by 0
最近のエピソード

Apr 22, 2025
Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP to create broad T-cell responses
S1 E15 • 41 mins

Apr 7, 2025
Elias Zerhouni and Andy Plump discuss the future of multispecific biologics
S1 E14 • 36 mins

Apr 1, 2025
Candel Therapeutics CEO Paul Peter Tak and IDEA Pharma CEO Mike Rea on why they believe a different mindset and good communication are keys to succeeding with new innovations in biotech
S1 E13 • 31 mins

Mar 5, 2025
Korro Bio's Ram Aiyar and Novo Nordisk's Uli Stilz discuss their RNA editing collaboration, the field of genetic medicine, and the future of drug discovery
S1 E12 • 31 mins

Feb 24, 2025
Devan Shah and Namita Bisaria, experts in the field of RNA therapies, discuss the year ahead in RNA - opportunities, challenges, AI, fundraising, and more
S1 E11 • 26 mins

言語
英語
国
アメリカ合衆国
Feed Host
ウェブサイト
フィード
更新をリクエストする
更新には数分かかる場合があります。